trending Market Intelligence /marketintelligence/en/news-insights/trending/owrgybkjkrz-8uqhnb3kpw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

BARD1 Life Sciences plans to raise A$1.3M via placement of shares

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


BARD1 Life Sciences plans to raise A$1.3M via placement of shares

BARD1 Life Sciences Ltd. agreed to sell 86,666,666 shares at 1.5 Australian cents each to a group of investors.

The company expects to raise A$1.3 million through the placement, which will go toward its ongoing research and development programs, as well as commercial initiatives and general working capital purposes.

The placement is expected to settle by March 26.

Australia-based BARD1 Life Sciences develops therapies and diagnostic tests for cancer.